3647 related articles for article (PubMed ID: 34635121)
1. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
3. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
6. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
Patel AK; Singh S
Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
Laha D; Grant R; Mishra P; Nilubol N
Front Immunol; 2021; 12():656908. PubMed ID: 33986746
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
Allam A; Yakou M; Pang L; Ernst M; Huynh J
Front Immunol; 2021; 12():767939. PubMed ID: 34858425
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
12. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
14. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
16. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.
Liu K; Huang A; Nie J; Tan J; Xing S; Qu Y; Jiang K
Front Immunol; 2021; 12():683332. PubMed ID: 34093586
[TBL] [Abstract][Full Text] [Related]
17. A framework for advancing our understanding of cancer-associated fibroblasts.
Sahai E; Astsaturov I; Cukierman E; DeNardo DG; Egeblad M; Evans RM; Fearon D; Greten FR; Hingorani SR; Hunter T; Hynes RO; Jain RK; Janowitz T; Jorgensen C; Kimmelman AC; Kolonin MG; Maki RG; Powers RS; Puré E; Ramirez DC; Scherz-Shouval R; Sherman MH; Stewart S; Tlsty TD; Tuveson DA; Watt FM; Weaver V; Weeraratna AT; Werb Z
Nat Rev Cancer; 2020 Mar; 20(3):174-186. PubMed ID: 31980749
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
20. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
Yamamoto Y; Kasashima H; Fukui Y; Tsujio G; Yashiro M; Maeda K
Cancer Sci; 2023 Jan; 114(1):16-24. PubMed ID: 36197901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]